Most early-stage failure is scaling something that did not work yet.

The Startup Genome finding — that premature scaling is the primary reason startups and small businesses fail — matches what a diagnosis usually turns up. The business did not lack ambition. It added cost ahead of proof.

These pieces are about the order: what has to be true before headcount, what a founder can learn for almost nothing, and how to tell a real signal from a friendly one. Blue Mango also runs Check The Idea as a separate paid service for validating an idea before capital commits to it.